Kai Zhang

17.9k citations
533 papers · 11.8k indexed · 1 hit paper · h-index 56
Topics
Epigenetics and DNA Methylation (40 papers)MicroRNA in disease regulation (36 papers)RNA modifications and cancer (31 papers)

In The Last Decade

Kai Zhang

489 papers receiving 11.7k citations

Hit Papers

HBO1 catalyzes lysine lactylation and mediates histone H3...2024202620252024255075

Peers

Kai Zhang
Comparison fields: 5 of 196
  • Molecular Biology 6.2k
  • Cancer Research 1.8k
  • Oncology 1.2k
  • Biomedical Engineering 1.1k
  • Epidemiology 1.0k
Replace Xiaoyan Liu with:
Xiaoyan Liu China
Yifei Wang China
Qiang Liu China
Susan A. Elmore United States
Chih‐Yang Huang Taiwan
Ali Mobasheri United Kingdom
Jing Liu China
Ying Liu China
Lu Lu China
Fei Liu China
Kai Zhang relative to Xiaoyan Liu China Xiaoyan Liu's profile →
Citations per field
00.5×1.6×
Xiaoyan Liu · 1×
Citations per year

Countries citing papers authored by Kai Zhang

Since Specialization
Citations

This map shows the geographic impact of Kai Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Zhang more than expected).

Fields of papers citing papers by Kai Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Zhang. The network helps show where Kai Zhang may publish in the future.

Co-authorship network of co-authors of Kai Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Zhang. A scholar is included among the top collaborators of Kai Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Zhang. Kai Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 8
3 2
4 2
5 1
6 0
7 7
8 3
9 0
10 3
11 3
12 4
13 3
14 11
15 1
16 34
17 53
18 113
19 3
20 128

About Kai Zhang

Kai Zhang is a scholar working on Cancer Research, Geriatrics and Gerontology and Molecular Biology, having authored 533 papers that have together received 11.8k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (40 papers), MicroRNA in disease regulation (36 papers) and RNA modifications and cancer (31 papers). The work is most often cited by research in Cancer Research (1.8k citations), Molecular Biology (6.2k citations) and Geriatrics and Gerontology (228 citations). Kai Zhang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yuegang Zuo, Yingming Zhao, Shanshan Tian, Longbang Chen, Kaushik Banerjee, Enguo Fan, Guijin Zhai, Zhi Yao, Zhongyi Cheng and Shuzhen Zheng. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026